Cargando…

Platelet-Rich Plasma in Maxillary Sinus Augmentation: Systematic Review

Background: Sinus augmentation can be performed with or without grafting biomaterials, and to date, there is no quality evidence regarding the augmentation of the sinus floor using only platelet concentrates, which can improve the healing period and enhance bone regeneration by stimulating angiogene...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortega-Mejia, Holmes, Estrugo-Devesa, Albert, Saka-Herrán, Constanza, Ayuso-Montero, Raúl, López-López, José, Velasco-Ortega, Eugenio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040697/
https://www.ncbi.nlm.nih.gov/pubmed/32019255
http://dx.doi.org/10.3390/ma13030622
_version_ 1783501046806478848
author Ortega-Mejia, Holmes
Estrugo-Devesa, Albert
Saka-Herrán, Constanza
Ayuso-Montero, Raúl
López-López, José
Velasco-Ortega, Eugenio
author_facet Ortega-Mejia, Holmes
Estrugo-Devesa, Albert
Saka-Herrán, Constanza
Ayuso-Montero, Raúl
López-López, José
Velasco-Ortega, Eugenio
author_sort Ortega-Mejia, Holmes
collection PubMed
description Background: Sinus augmentation can be performed with or without grafting biomaterials, and to date, there is no quality evidence regarding the augmentation of the sinus floor using only platelet concentrates, which can improve the healing period and enhance bone regeneration by stimulating angiogenesis and bone formation. The main objective of this paper was to assess the effect of the sole use of platelet concentrates in sinus augmentation in terms of newly formed bone, augmented bone height, and clinical outcomes and to assess the additional beneficial effects of platelet-rich fibrin (PRF) in combination with other grafting biomaterials. Methods: A systematic review was conducted following Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Pooled analyses were performed with the Review Manager software. Results: For sinus elevation only using platelet concentrates, 11 studies met the inclusion criteria and were included for qualitative synthesis. Only one study was a clinical trial, which reported improved outcomes for the allograft group compared to the titanium-PRF (T-PRF) group. A total of 12 studies where PRF was used in addition to grafting biomaterials met eligibility criteria and were included in the review. Results from meta-analyses provided no additional beneficial effects of PRF in sinus augmentation in terms of bone height and percentage of soft tissue area. There was a statistically significant lower percentage of residual bone substitute material in the PRF (+) group compared to the PRF (−) group. The percentage of newly formed bone was slightly higher in the PRF (+) group, but this was not statistically significant. Conclusion: There is no robust evidence to make firm conclusions regarding the beneficial effects of the sole use of platelet concentrates in sinus augmentation. However, studies have shown favorable outcomes regarding implant survival, bone gain, and bone height. The use of PRF with other grafting biomaterials appears to provide no additional beneficial effects in sinus lift procedures, but they may improve the healing period and bone formation. Well-conducted randomized clinical trials (RCTs) are necessary to confirm the available results to provide recommendations for the clinical practice.
format Online
Article
Text
id pubmed-7040697
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70406972020-03-09 Platelet-Rich Plasma in Maxillary Sinus Augmentation: Systematic Review Ortega-Mejia, Holmes Estrugo-Devesa, Albert Saka-Herrán, Constanza Ayuso-Montero, Raúl López-López, José Velasco-Ortega, Eugenio Materials (Basel) Review Background: Sinus augmentation can be performed with or without grafting biomaterials, and to date, there is no quality evidence regarding the augmentation of the sinus floor using only platelet concentrates, which can improve the healing period and enhance bone regeneration by stimulating angiogenesis and bone formation. The main objective of this paper was to assess the effect of the sole use of platelet concentrates in sinus augmentation in terms of newly formed bone, augmented bone height, and clinical outcomes and to assess the additional beneficial effects of platelet-rich fibrin (PRF) in combination with other grafting biomaterials. Methods: A systematic review was conducted following Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Pooled analyses were performed with the Review Manager software. Results: For sinus elevation only using platelet concentrates, 11 studies met the inclusion criteria and were included for qualitative synthesis. Only one study was a clinical trial, which reported improved outcomes for the allograft group compared to the titanium-PRF (T-PRF) group. A total of 12 studies where PRF was used in addition to grafting biomaterials met eligibility criteria and were included in the review. Results from meta-analyses provided no additional beneficial effects of PRF in sinus augmentation in terms of bone height and percentage of soft tissue area. There was a statistically significant lower percentage of residual bone substitute material in the PRF (+) group compared to the PRF (−) group. The percentage of newly formed bone was slightly higher in the PRF (+) group, but this was not statistically significant. Conclusion: There is no robust evidence to make firm conclusions regarding the beneficial effects of the sole use of platelet concentrates in sinus augmentation. However, studies have shown favorable outcomes regarding implant survival, bone gain, and bone height. The use of PRF with other grafting biomaterials appears to provide no additional beneficial effects in sinus lift procedures, but they may improve the healing period and bone formation. Well-conducted randomized clinical trials (RCTs) are necessary to confirm the available results to provide recommendations for the clinical practice. MDPI 2020-01-30 /pmc/articles/PMC7040697/ /pubmed/32019255 http://dx.doi.org/10.3390/ma13030622 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ortega-Mejia, Holmes
Estrugo-Devesa, Albert
Saka-Herrán, Constanza
Ayuso-Montero, Raúl
López-López, José
Velasco-Ortega, Eugenio
Platelet-Rich Plasma in Maxillary Sinus Augmentation: Systematic Review
title Platelet-Rich Plasma in Maxillary Sinus Augmentation: Systematic Review
title_full Platelet-Rich Plasma in Maxillary Sinus Augmentation: Systematic Review
title_fullStr Platelet-Rich Plasma in Maxillary Sinus Augmentation: Systematic Review
title_full_unstemmed Platelet-Rich Plasma in Maxillary Sinus Augmentation: Systematic Review
title_short Platelet-Rich Plasma in Maxillary Sinus Augmentation: Systematic Review
title_sort platelet-rich plasma in maxillary sinus augmentation: systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040697/
https://www.ncbi.nlm.nih.gov/pubmed/32019255
http://dx.doi.org/10.3390/ma13030622
work_keys_str_mv AT ortegamejiaholmes plateletrichplasmainmaxillarysinusaugmentationsystematicreview
AT estrugodevesaalbert plateletrichplasmainmaxillarysinusaugmentationsystematicreview
AT sakaherranconstanza plateletrichplasmainmaxillarysinusaugmentationsystematicreview
AT ayusomonteroraul plateletrichplasmainmaxillarysinusaugmentationsystematicreview
AT lopezlopezjose plateletrichplasmainmaxillarysinusaugmentationsystematicreview
AT velascoortegaeugenio plateletrichplasmainmaxillarysinusaugmentationsystematicreview